Second Primary Cancers in a Population-Based Mesothelioma Registry

Area of Science:

• Oncology
• Epidemiology
• Cancer Research

Background:

• The occurrence of a second primary cancer (SPC) in patients diagnosed with pleural mesothelioma (PM) is a significant clinical concern.
• SPCs may indicate shared carcinogenic pathways or underlying genetic predispositions in patients with PM.
• Understanding the impact of SPCs on PM prognosis is crucial for patient management.

Purpose of the Study:

• To investigate the incidence of SPCs in pleural mesothelioma patients.
• To evaluate the prognostic implications of SPCs on overall survival (OS) in PM.
• To explore potential links between SPCs and genetic susceptibility in mesothelioma.

Main Methods:

• Retrospective analysis of 6,646 PM cases from the Lombardy Mesothelioma Registry (2000-2018).
• Kaplan-Meier analysis for median survival time estimation.
• Univariate and multivariate Cox regression models to determine hazard ratios (HR) and 95% confidence intervals (CI) for mortality.

Main Results:

• The overall median survival for PM patients was 10.9 months; age and histotype were key prognostic factors.
• No significant difference in OS was observed between patients with and without SPCs (10.5 vs. 10.9 months, HR 1.03, p=0.40).
• A subset of 150 patients with non-epithelioid mesothelioma and SPC showed significantly shorter OS (5.4 vs. 7.1 months, HR 1.21, p=0.03).

Conclusions:

• The presence of an SPC does not generally impact the prognosis of pleural mesothelioma patients.
• SPCs are associated with reduced overall survival specifically in non-epithelioid mesothelioma subtypes.
• Further research is warranted to elucidate the role of SPCs as potential markers of genetic susceptibility in mesothelioma.